H3K9 methylation drives resistance to androgen receptor-antagonist therapy in prostate cancer. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1073/pnas.2114324119
PubMed Identifier: 35584120
Publication URI: http://europepmc.org/abstract/MED/35584120
Type: Journal Article/Review
Volume: 119
Parent Publication: Proceedings of the National Academy of Sciences of the United States of America
Issue: 21
ISSN: 0027-8424